TheEdgeResearch
Home / Stocks / SBFM

Sunshine Biopharma, Inc. (SBFM)

NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
$2.23 ▼ -5.11%
Market Cap
$4.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.35
52-Wk Range
2.23-464
CEO
Steve N. Slilaty
Country
US
Currency
USD

Sunshine Biopharma, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Fort Lauderdale, FL, US. The stock last traded at $2.23, down 5.11% on the session, giving a market capitalisation of $4.7M. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -17.5%. Its beta of 1.35 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.13
Price / Book
0.02
EV / EBITDA
1.67
Gross margin
29.9%
Operating margin
-16.8%
Net margin
-17.5%
Return on equity
—
Debt / equity
0.02
Current ratio
6.47
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
50
IPO date
2022-02-15
Headquarters
Fort Lauderdale, FL, US
About Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.

Comparable companies

Sunshine Biopharma, Inc. is most often compared with the following Healthcare names:

ACXPBFRICHEKEVOKHCWBIINNLUCYPFSASNOAYCBD
More research on SBFM
SBFM technical analysis SBFM TheEdge Score Compare against peers
Open full interactive analysis & DCF →